Kevin Gopal

Canberra, Australia-The Australian Pharmaceutical Manufacturers' Association has denounced calls from the country's media and some of its doctors to drastically curtail drug promotion. APMA chief executive Alan Evans says any such move would severely affect the healthcare of millions of people in Australia and could even result in premature death.

London, UK - According to the magazine Health Which?, patients fail to receive full information about the efficacy and safety of antidepressants, including the risks of withdrawal and suicidal behavior.

More than a fifth of the people in the European Union are age 16 or under, yet at least half of the medicines in use there have not been tested on children. As a result, the region suffers from a lack of information about the safety and efficacy of pediatric medicines and of off-label pediatric use that medical experts say could cause adverse effects and even death.

GSK Faces Bribe Charges, Changing of the Guard

Capetown-In March, ruling on a case initiated by the Treatment Action Campaign, Save Our Babies, and the Children's Rights Centre, Judge Chris Botha ordered the South African government to provide the anti-retroviral nevirapine to all HIV-positive pregnant women.

A new report by Médecins Sans Frontières (MSF) scotches the myth that the most effective forms of malaria treatment are too expensive for East African countries.